findmyKOL

Dipan Shah, MD

Enriched profile

Chief, Division of Cardiovascular Imaging, Department of Cardiology; Beverly B. and Daniel C. Arnold Distinguished Centennial Chair; Professor of Cardiology, Academic Institute; Program Director, Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship · Houston Methodist

ORCIDNPI
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Artery Disease / ACS+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2026

Dipan Shah is Chief, Division of Cardiovascular Imaging, Department of Cardiology; Beverly B. and Daniel C. Arnold Distinguished Centennial Chair; Professor of Cardiology, Academic Institute; Program Director, Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship at Houston Methodist. OpenAlex indexes 457 publications with 12,167 citations (h-index 47); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Dipan Shah, MD, is Chief, Division of Cardiovascular Imaging, Department of Cardiology at Houston Methodist (DeBakey Heart & Vascular Center, Houston Methodist Hospital), Houston, TX. The public record shows 457 publications with 12,167 citations (h-index 47), centered on Coronary Artery Disease / ACS, Heart Failure. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 21 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · European heart journal. Cardiovascular Imaging
  • Top research focus: Coronary Artery Disease / ACS
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 21 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS2 trialsCoronary Artery Disease2 trialsMitral Valve Insufficiency1 trialHeart Failure1 trialCardiovascular Diseases1 trialVascular Diseases1 trial

Research focus

OpenAlex concept fingerprint
Coronary Artery Disease / ACSHeart Failure

Drugs & molecules

across trials, industry payments and publications
Arcalystgeneric · RilonaceptClinical trialsIndustry payments45PublicationsRepathageneric · EvolocumabClinical trialsIndustry payments21PublicationsLeqviogeneric · InclisiranClinical trialsIndustry payments12Publications

Works with

trial sponsors and companies reporting payments
Kiniksa Pharmaceuticals, Ltd.Clinical trialsIndustry payments35Siemens Medical Solutions USA, Inc.Clinical trialsIndustry payments32Amgen Inc.Clinical trialsIndustry payments21

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
457publications

Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.

12,167citations

Total citations across indexed works.

47h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
21companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2024–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    88.4%
    Statin27.5%
    Rosuvastatin Calcium59%Atorvastatin Calcium41%
    Part D27 patients
    Beta blocker23.9%
    Carvedilol53%Metoprolol Succinate47%
    Part D18 patients
  • Blood & clotting

    9.4%
    Factor Xa inhibitor7.1%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor2.4%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.2%
    SGLT2 inhibitor2.2%
    Farxiga100%
    Part D<11 patients
Where care is delivered (Part B)87.7% facility · 12.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20242026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/dipan-shah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Dipan-Shah-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • X / Twitter

    x.com/DipanJShah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    mdvideos.houstonmethodist.org/participant/dipan-shah-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdvideos.houstonmethodist.org
  • Other

    pmc.ncbi.nlm.nih.gov/articles/PMC3782316

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov
  • Other

    scholars.houstonmethodist.org/en/persons/dipan-j-shah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org
  • Program Director

    Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship, Houston Methodist

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org
  • Guest Editor

    Methodist DeBakey Cardiovascular Journal (special issue on cardiac MRI)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.